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MyogenesisCells that express MyoD mRNA, the G8 antigen and the bone morphogenetic protein (BMP) inhibitor noggin
(Nog) are present in the epiblast before gastrulation. Ablation of “Myo/Nog” cells in the blastocyst results in an
expansion of canonical BMP signaling and prevents the expression of noggin and follistatin before and after
the onset of gastrulation. Once eliminated in the epiblast, they are neither replaced nor compensated for as
development progresses. Older embryos lacking Myo/Nog cells exhibit severe axial malformations. Although
Wnts and Sonic hedgehog are expressed in ablated embryos, skeletal muscle progenitors expressing Pax3 are
missing in the somites. Pax3+ cells do emerge adjacent to Wnt3a+ cells in vitro; however, few undergo
skeletal myogenesis. Ablation of Myo/Nog cells also results in ectopically placed cardiac progenitors and
cardiomyocytes in the somites. Reintroduction of Myo/Nog cells into the epiblast of ablated embryos restores
normal patterns of BMP signaling, morphogenesis and skeletal myogenesis, and inhibits the expression of
cardiac markers in the somites. This study demonstrates that Myo/Nog cells are essential regulators of BMP
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Cells of the epiblast undergo dramatic alterations in position,
adhesion and gene expression that lead to the development of the
primitive streak, establishment of three germ layers during gastrula-
tion and formation of the nervous system. These events are mediated
by complex communication networks involving several families of
diffusible proteins, including Wnts, Fibroblast Growth Factors and
members of the Transforming Growth Factor family (Gilbert, 2010;
Stern, 2006). The response of cells to extracellular factors depends, in
part, on where they lie within the concentration gradient and the
presence of inhibitors of signal transduction (Ashe and Briscoe, 2006).
In the chick embryo, the ﬁrst visible sign of primitive streak
formation is an increase in cell density in the posterior/medial, stage 2
epiblast (Bellairs, 1986). A hallmark of primitive streak formation is
the disappearance of bone morphogenetic protein 4 (BMP4) and its
signal transducer, phosphorylated Smad1/5/8 (p-Smad1/5/8), from
this region of the epiblast (Faure et al., 2002; Streit et al., 1998;Wilsonet al., 2000). The downregulation of BMP signaling in the epiblast was
attributed to suppression of BMP4 gene transcription by FGF3 (Wilson
et al., 2000) and blocking BMP receptor activation by chordin (Streit
et al., 1998). Two other BMP inhibitors, noggin and follistatin, were
not detected in the epiblast of the prestreak chick embryo (Chapman
et al., 2002; Streit et al., 1998; Wilson et al., 2000); however, both of
these BMP inhibitors are expressed in the early Xenopus embryo
(Khokha et al., 2005; Wessely et al., 2001). Once gastrulation begins,
noggin, follistatin, chordin and other BMP inhibitors are synthesized
in an important signaling center located at the anterior end of the
primitive streak called Hensen's node in the chick, the node in
mammals and Spemann's organizer in amphibians (Anderson et al.,
2002; Bachiller et al., 2000; Bouwmeester et al., 1996; Capdevila and
Johnson, 1998; Chapman et al., 2002; Glinka et al., 1998; Hansen et al.,
1997; Hemmati-Brivanlou et al., 1994; Hsu et al., 1998; Khokha et al.,
2005; Klingensmith et al., 1999; Lamb et al., 1993; McMahon et al.,
1998; Sasai et al., 1994; Smith and Harland, 1992; Streit et al., 1998;
Wessely et al., 2001).
The roles of BMP inhibitors in multiple developmental processes
have been explored, in part, by adding them to embryonic tissues and
by molecular knockout or knockdown of their expression. While
addition of noggin or chordin to the embryo induces the formation of
ectopic primitive streaks in chick and Xenopus embryos (Frisch and
Wright, 1998; Graff et al., 1994; Hawley et al., 1995; Streit et al., 1998;
Streit and Stern, 1999b; Suzuki et al., 1997), gastrulation does occur in
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(Anderson et al., 2002; Bachiller et al., 2000; Brunet et al., 1998;
Klingensmith et al., 1999; McMahon et al., 1998; Stottmann et al.,
2006). BMP inhibitors were also shown to induce neural tissue in
Xenopus embryos, maintain the expression of neural markers,
establish the border between neural and epidermal tissues in the
chick embryo, and regulate morphogenesis and patterning of the
mouse neural tube (Anderson et al., 2002; Harland and Gerhart, 1997;
Hartley et al., 2001; Khokha et al., 2005; Linker and Stern, 2004;
Lumsden and Krumlauf, 1996; McMahon et al., 1998; Sasai et al.,
1994; Smith and Harland, 1992; Stottmann et al., 2006; Streit and
Stern, 1999a; Streit et al., 1997, 1998; Tanabe and Jessell, 1996; Wills
et al., 2010). Chordin null mice exhibit defects in the development of
the skeleton, ear, pharynx and cardiovascular system (Bachiller et al.,
2000), whereas the absence of follistatin results in musculoskeletal
defects and abnormalities in whisker, tooth and skin development
(Matzuk et al., 1995). Knockout of noggin in themouse embryo results
in neural tube patterning and fusion defects, enlargement of the
notochord, malformations of the heart, lungs, skeleton and esophagus,
and a decrease in skeletal muscle in the somites (Anderson et al.,
2002; Bachiller et al., 2000; Brunet et al., 1998; Choi et al., 2007;
McMahon et al., 1998; Que et al., 2006; Stottmann et al., 2006;Weaver
et al., 2003).
A source of noggin in the chick embryo during the period of
organogenesis are cells that also expressmRNA for the skeletal muscle
speciﬁc transcription factor MyoD and the cell surface G8 antigen
(Gerhart et al., 2006, 2009). These cells arise in the early epiblast and
are integrated into all three germ layers during gastrulation (Gerhart
et al., 2000, 2006; Strony et al., 2005). Later they are found in multiple
tissues and organs, including the somites, eyes, heart and central
nervous system (Gerhart et al., 2001, 2006, 2009). The importance of
MyoD-positive (+) epiblast cells as a noggin delivery system in the
eyes and somites was demonstrated by ablating them during early
stages of primitive streak formation. Ablated embryos exhibited eye
defects, a herniation of organs through the ventral body wall and a
severe reduction in skeletal muscle (Gerhart et al., 2006, 2009).
Myogenic progenitor cells expressing the Pax3 transcription factor
were present in the somites of ablated embryos; however, they were
unable to differentiate unless they were exposed to exogenous noggin
(Gerhart et al., 2006).
In the following study we examinedwhetherMyoD+ cells express
noggin while they reside within the epiblast and deﬁned the
consequences of ablating them in the blastocyst prior to the formation
of the primitive streak. Noggin producing, MyoD+(Myo/Nog) cells
regulate BMP signaling and follistatin expression during the hours
leading up to primitive streak formation. The double noggin/follistatin
knockdown resulting from the ablation of Myo/Nog cells in the
blastocyst has profound consequences on development that includes
a disruption in neurulation, an inhibition of the emergence of skeletal
muscle progenitor cells and ectopic cardiomyogenic cells in the
somites.
Materials and methods
Immunoﬂuorescence localization and in situ hybridization
White Leghorn chick embryos (BE Eggs, York, PA) were staged
according to the method of Eyal-Giladi and Kochav (1976) (stages X–
XII) or Hamburger and Hamilton (1951) (stage 2 and older embryos).
Whole stage X-4 embryos and 10 μm parafﬁn sections from 3 to 6 day
embryos were double labeled for the G8 antigen and mRNAs by
incubating with the G8 IgM MAb and DyLight 488 conjugated goat
anti-mouse IgM μ chain (Invitrogen/Molecular Probes, Eugene, OR),
followed by incubation in Cy3 labeled 3DNA™ dendrimers (Geni-
sphere, LLC, Hatﬁeld, PA) conjugated with an antisense cDNA
sequence for chicken MyoD (5′-TTCTCAAGAGCAAATACTCAC-CATTTGGTGATTCCGTGTAGTA-3′) (Dechesne et al., 1994) (L34006),
chicken noggin (5′-TCTCGTTAAGATCCTTCTCCTTGGGGTCAAA-3′)
(Tonegawa and Takahashi, 1998) (NM_204123) or chicken Wnt1
(5′-CAGATCTCGGCCCTTCTCGCTGGAATCCACAAA-3′) (AY655699.1;
Jensen, J.L. et al., Direct Submission) (Gerhart et al., 2004a, 2006,
2009). Double labeling was also carried out with IgG MAbs to Pax3
(Venters et al., 2004), sarcomeric myosin heavy chain (MF20 MAb)
(Bader et al., 1982), neuroﬁlament associated antigen (3A10 MAb)
(Furley et al., 1990), the notochord marker NOT1, cardiac troponin I
(TI-1 MAb) (Saggin et al., 1989), Shh (5E1 MAb) (Ericson et al., 1996)
(all obtained from the Developmental Studies Hybridoma Bank, Iowa
City, IA), MyoD1 (NCL-MyoD1 MAb from Vector Laboratories,
Burlingame, CA), BMP2 (Sigma-Aldrich, St. Louis, MO) and cardiac
troponin T, isoform Ab-1 (MS-295-PO, Thermo Scientiﬁc, Fremont,
CA), and the following polyclonal antisera: goat anti-mouse noggin
(AF719, R&D Systems, Minneapolis, MN), rabbit anti-mouse chordin
(ab24562, Abcam, Cambridge, MA), goat anti-human follistatin
(sc-23553, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-
human BMP4 (5674R-100, Biovision, Mountain View, CA), rabbit
anti-human p-Smad1/5/8 (9511, Cell Signaling Technology,
Danvers, MA), rabbit anti-human Wnt3a (ab28472, Abcam), rabbit
anti-human GATA4 (ab25992, Abcam) and rabbit anti-human
Smad4 (sc-7154, Santa Cruz Biotechnology). IgG MAbs were
tagged with afﬁnity puriﬁed, goat anti-mouse IgG conjugated
with rhodamine (Jackson ImmunoResearch, West Grove, PA) and
ﬂuorescein or rhodamine labeled, rabbit anti-mouse IgG2b or IgG1
(Fitzgerald Industries, Inc., Concord, MA). Polyclonal antibodies were
labeled with donkey anti-goat and goat anti-rabbit IgG conjugated with
ﬂuorescein, DyLight 488 or DyLight 549 (Jackson ImmunoResearch,
Chemicon and Invitrogen/Molecular Probes). Nuclei were counter-
stained with Hoechst dye 33258 (1 μg/ml Hanks buffer) (Sigma-
Aldrich). Experiments included sections stained with secondary
antibodies alone to determine the level of background ﬂuorescence.
Embryos and sections were mounted in Gelmount (Biomeda,
Foster City, CA) or Elvanol (Dupont, Wilmington, DE) and analyzed
with a Nikon Eclipse E800 epiﬂuorescence microscope (Optical
Apparatus) equipped with 4× NA 0.2, 40× oil NA and 60× oil NA 1.4
objectives and the following ﬁlters: excitation 530–560, barrier 573–
648 for Cy3 and Rhodamine; excitation 465–495, barrier 515–555 for
Alexa 488; excitation 330–380, barrier 435–485 for Hoechst dye.
Images were captured and produced with the Evolution QE Optronics
video camera (Media Cybernetics) and Image Pro Plus image
analysis software program (Phase 3 Imaging Systems). Figures were
annotated and adjusted for brightness and contrast using Adobe
Photoshop 6.0.
Ablating cells in the epiblast and incubation of embryos
MyoD+ cells were ablated in stage X–XII epiblasts by incubating
embryos with the G8 MAb and lysing labeled cells with baby rabbit
complement (Cedar Lane, Inc., Hornby, Ontario, Canada) (Gerhart
et al., 2006, 2008, 2009). For these studies, antibody and complement
solutions were applied to the vitelline membrane as the embryo
resided on the yolk (Gerhart et al., 2008). Similar numbers of cells
bound the G8 MAb whether the solutions were applied to isolated
embryos or embryos within the vitelline membrane. Control embryos
were incubated in Hanks buffer, complement only or the D4 MAb and
complement. Hybridoma cells producing the D4 MAb were generated
by immunizing BALB/c mice with three inoculations of 106 cells
obtained from the posterior 12 pairs of somites and segmental plate
mesoderm of stage 12–14 chick embryos, as described previously for
the generation of the G8 MAb (Gerhart et al., 2001). Cell lysis and
death were visualized by incubating embryos in trypan blue (Gerhart
et al., 2006) and staining for terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) (Roche Diagnostics, Mannheim,
Germany). Control and ablated embryos were incubated on the yolk
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2008) and grown for 5–6 days. Curvature of the stage 4 primitive
streak was calculated by selecting the point of greatest deviation from
linear as the vertex and measuring the angle between lines drawn
from the vertex to the rostral and caudal ends of the streak.Isolation and microinjection of G8+ and G8− epiblast cells
G8+ and G8− epiblast cells were isolated from stage X–XII
embryos by removing and dissociating the epiblasts, labeling the cells
in suspension with the G8 MAb and rat anti-mouse IgM microbeads,
and sorting on a MiniMACS magnetic column (Miltenyi Biotech, Inc)
(Gerhart et al., 2004b, 2007; Strony et al., 2005). Sorted cells were
examined for expression of MyoD and noggin mRNAs, and noggin
protein by centrifuging cells onto slides and staining with ﬂuorescent
dendrimers to mRNA and the anti-noggin antibody. Nuclei were
counterstained with Hoechst dye. Forty ﬁve minutes after ablating
embryos with the G8 MAb and complement, ﬁve G8+ or G8− cells
suspended in 9 μl of a 70% glycerol solution containing fast green dye
were microinjected directly into three sites within the posterior/
medial epiblast using the Nanoject II microinjector (Drummond
Scientiﬁc, Broomall, PA).Preparation of somite and cardiac cell cultures
Cultures of somite cells were prepared as described previously
(George-Weinstein et al., 1994). Untreated or G8 and complement
ablated embryos were grown to stages 10–12, removed from the yolk
and placed in PBS. Somites 4–16 (below the level of the heart) were
isolated from surrounding tissues of the embryo and dissociated in
0.25% trypsin–0.02% EDTA. Cells were plated at 2×104 cells in 15 μl of
culture medium containing Dulbecco's modiﬁed Eagle's medium
(DMEM) with 5% fetal bovine serum, 5% horse serum, 1% penicillin/
streptomycin (GIBCO/Invitrogen) and 5% chick embryo extract on
tissue culture dishes coated with 1% gelatin (Sigma-Aldrich) and
human serum ﬁbronectin (GIBCO/Invitrogen). Following cell attach-
ment, dishes were ﬂooded with 1.5 ml serum and hormone free
DMEM/F12 medium (GIBCO/Invitrogen). Other dishes were plated
with pieces of the neural tube and notochord removed from untreated
stage 10–12 embryos at the level of somites 4–16, followed by the
addition of somite cells. Cells were ﬁxed in 2% formaldehyde on the
ﬁfth day in culture. Differences between populations were deter-
mined by the Wilcoxon rank sum test. Cardiac cell cultures were
prepared by dissecting the hearts from stage 12 embryos, dissociating
in trypsin–EDTA and plating and growing cells by the same method
used to culture somite cells.Fig. 1. Maps of blastula and gastrula stage chick embryos. Drawings of stages XI, 2 and 4
photomicrographs of Figs. 2–4 and 9. pme: posterior/medial epiblast, ks: Koller's sickle; pl
node.Results
G8+/MyoD+ cells express noggin in the epiblast
Double label experiments revealed that blastula stageX–XII embryos
(Fig. 1A) (Eyal-Giladi and Kochav, 1976) contained 14±5 (mean±
standard deviation, n=24) G8+/MyoD mRNA+ cells in the posterior/
medial epiblast (Fig. 2B). Noggin mRNA and protein were detected in
98%±6 (n=9) and 71%±21 (n=4) of cells labeled with the G8 MAb,
respectively (Figs. 2C and D). Only two nogginmRNA+/G8− cells were
found in the anterior epiblast of two out of 25 embryos. In the stage 2
embryo (Fig. 1B), G8+ cells were present in the developing primitive
streak (Fig. 2G). By stage 2+, G8+ cells continued to occupy the streak
as it narrowed and elongated along the midline. The number of G8+
cells increased to 62±13 (n=15). Noggin was expressed in 98%±7
(n=15) of G8+ cells (Fig. 2G). Noggin producing, G8+/MyoD+ cells
are hereafter called Myo/Nog cells.
Myo/Nog cells were examined for the expression of two other BMP
inhibitors, chordin and follistatin. Chordin was found in the blastocyst
adjacent to Koller's sickle but was not co-localized with G8 (Fig. 2E).
Follistatin was not detected in the embryo until stage 2 when it
appeared in 164±11 (n=5) cells located in the posterior/lateral
epiblast and Koller's sickle (Figs. 2H and I). Staining for follistatin did
not overlap with that of G8, noggin or chordin.Myo/Nog cells do not reappear in the epiblast following their ablation in
the blastocyst
The role of Myo/Nog cells in regulating BMP signaling in the early
embryo was examined by eliminating them in the blastocyst.
Following treatment with G8 and complement, embryos were
incubated with trypan blue to visualize lysed cells. The ablation
procedure produced 15±3 (n=7) trypan blue+cells that were
located in the same region of the epiblast as the cells that were
ﬂuorescently labeled with the G8 MAb (Fig. 2J).
A control for this experiment was embryos incubated with the D4
MAb and complement. The D4 MAb labeled a cell surface antigen
present in a separate population from those that express MyoD
(Figs. 2K and L). Some D4+ cells were located in the posterior/medial
epiblast (Fig. 2L) but most resided in the central epiblast (Fig. 2K).
Incubation with the D4 MAb and complement lysed 76±12 cells
(n=6) (Fig. 2M). Embryos incubatedwith theD4MAb (n=4), G8MAb
(n=4) or complement alone (n=3) contained only 5±3 (n=11)
trypan blue stained cells randomly distributed throughout the epiblast.
The G8 and D4 MAbs were reapplied 18 h following ablation to
monitor whether their target populations re-emerged in the epiblast.
No G8+ cells were detected in seven embryos. The remaining twoembryos are labeled for those regions that are illustrated in the high magniﬁcation
e: posterior/lateral epiblast, ce: central epiblast, ps: primitive streak, and hn: Hensen's
Fig. 2. Localization and ablation of G8+ and D4+ cells in the epiblast. Stage X-2 embryos were double labeled with the G8 or D4 MAb and dendrimers to MyoD or noggin mRNA
(NogM), or antibodies to BMP inhibitors. The colors of the ﬂuorescent tags are indicated in each panel. Overlap of red and green appears yellow/white in merged images. Nuclei were
stained with Hoechst dye. The photographs of stage XI (A) and stage 2 (F) embryos illustrate the areas shown at high magniﬁcation in ﬂuorescence micrographs. G8+ cells co-
expressing MyoD (B) and noggin mRNA (C) and noggin protein (NogP) (D) were located in the posterior/medial epiblast (pme). Chordin+(Chor)/G8− cells were present in a
narrow band of cells along Koller's sickle (ks) in stage XI embryo (E). By stage 2, G8+/noggin+ cells were localized to the developing primitive streak (ps) (G). Staining for follistatin
(Fol) was concentrated in the posterior/lateral epiblast (ple) (H) and to a lesser extent along Koller's sickle where it did not overlap with G8+ cells (I). Trypan blue+cells were
present in the pme following treatment of with G8 and complement (J). D4+ cells lacking MyoD mRNA were present in the pme (K) and central epiblast (ce) (L). Ablation with D4
and complement produced trypan blue+cells in the ce (M) and pme. G8+ cells accumulated in the ce surrounding TUNEL labeled apoptotic ﬁgures (N). Cells stained with the G8
MAb were not present in the ce when both G8+ and D4+ cells were ablated simultaneously in the epiblast (Fig. 1O). Bar, 875 μm in A, F; 9 μm in B–E, G–I, K, L, N, O; 56 μm in J, M.
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suggesting they were undergoing apoptosis. The decrease in G8+
cells in stage 2 ablated embryos compared to untreated embryos was
statistically signiﬁcant (pb0.0001). No D4+ cells were observed in six
ablated embryos. The speciﬁcity of the ablation procedure was further
demonstrated by ablating D4+ cells, incubating the embryos
overnight and staining with the G8 MAb and TUNEL reagents to
mark dead cells. Whereas G8+ cells were present exclusively in
the posterior/medial epiblast of unablated embryos, after ablating the
D4+ population, cells expressing G8 or MyoD mRNA were also found
in the central epiblast where they surrounded TUNEL+ cell remnants
(Fig. 2N). G8+ cells did not emerge in the embryo when they were
ablated simultaneously with the D4+ cells (Fig. 2O). These experi-
ments demonstrate that incubation with the G8 or D4 MAbs and
complement ablates separate populations of cells, few, if any, G8+
and D4+ cells emerge in the embryo within a day after the original
populations are eliminated in the blastocyst, and G8+ cells respond to
cells undergoing apoptosis.
Ablation of Myo/Nog cells in the blastocyst inhibits noggin and follistatin
expression and expands BMP signaling
The consequences of Myo/Nog cell ablation on BMP signaling were
examined by staining stage 2–4 embryos for BMP inhibitors, BMPs
and p-Smad1/5/8, the downstream mediator of canonical BMP
signaling (Balemans and Van Hul, 2002). Ablation of Myo/Nog cells
in the blastocyst eliminated staining for noggin in three stage 2
embryos (Fig. 3B). A fourth ablated embryo contained two noggin+/
G8+ cells. Two noggin+/G8− cells were found in the anterior
epiblast of two other ablated embryos. Although follistatin was not
detected in Myo/Nog cells (Figs. 3H and I), their ablation in the
blastocyst prevented follistatin accumulation in ﬁve stage 2 embryos
(Fig. 3C). Follistatin was expressed in embryos ablated with the D4MAb and complement (Fig. 3D). Chordin continued to be synthesized
in embryos ablated with the G8 MAb (Fig. 3E), although the intensity
of ﬂuorescence was decreased compared to unablated embryos
(Fig. 3E).
In untreated stage 2–2+ embryos, BMP4 was present in clusters of
cells in the anterior/lateral epiblast and the posterior portion of the
developing primitive streak (Fig. 3F). BMP2 was synthesized in the
area opaca below Koller's sickle (Fig. 2G). While nuclear p-Smad1/5/8
was observed in the region of the area opaca containing BMPs 2 and 4
(Fig. 3H), p-Smad1/5/8 was not detected within the epiblast (Fig. 3I).
Cytoplasmic, but not nuclear staining for Smad4, p-Smad1/5/8's
binding partner, was found in the posterior/medial epiblast (Fig. 3J).
Following ablation of Myo/Nog cells, staining for BMP4 was
broadened in the posterior/medial epiblast (Fig. 3K). The staining
pattern of BMP2 in the area opaca of G8 ablated embryos was similar
to that of control embryos (Figs. 3L and G). While unablated and
D4 ablated embryos lacked detectable levels of p-Smad1/5/8
above Koller's sickle (Figs. 3I and O), G8 ablated embryos displayed
p-Smad1/5/8 staining throughout the posterior and central regions
of the epiblast (Figs. 3M and N). The increase in staining for p-
Smad1/5/8 within the epiblast indicates that embryos lacking
Myo/Nog cells exhibit abnormal BMP signaling by the initiation of
primitive streak formation.
One to two days following ablation, 63% of ablated embryos had
formed a primitive streak; however, the morphology of the streak
differed from that of control embryos. Whereas the primitive streaks
of untreated embryos (Figs. 1C and 4A) or embryos treated with
complement alone or the D4 MAb and complement (Figs. 4B and C)
were linear along the midline or appeared slightly curved (168°±6,
n=9), the streaks of G8 ablated embryos had more pronounced
curves (144° in Fig. 4D) or were shortened or displaced laterally
(Fig. 4E). Hensen's node was either difﬁcult to detect or appeared
thicker than the nodes of control embryos.
Fig. 3. Effects of Myo/Nog cell ablation on the expression of regulators of BMP signaling in the stage 2 embryo. Untreated embryos and G8 or D4/complement treated stage X–XII
embryos were incubated to stage 2 and double labeled with antibodies. The colors of the ﬂuorescent tags are indicated in each panel. The photograph of the stage 2 embryo
(A) illustrates the regions shown in the ﬂuorescence micrographs. Overlap of red and green appears yellow/white in merged images. After ablating G8+ cells in the stage X–XII
epiblast, neither G8 (B, C, E–I, K–N), noggin (NogP) (B) nor follistatin (Fol) (C) was detected in the stage 2 embryo. Ablation with the D4MAb did not affect follistatin expression (D).
Staining for chordin (Chor) was reduced along Koller's sickle (ks) in G8 ablated embryos (E). In untreated stage 2 embryos, BMP4+ cells surrounded Koller's sickle (F) and BMP2was
present below Koller's sickle (bks) (G). P-Smad1/5/8 was detected only below Koller's sickle (H) and did not overlap with G8+ cells in the posterior/medial epiblast (pme) (I).
Cytoplasmic staining for Smad4 was present in the pme (J). In G8 ablated embryos, staining for BMP4 was increased in the pme (K), BMP2 remained below Koller's sickle (L) and p-
Smad1/5/8 was expanded into the pme (M) and central epiblast (ce) (N). P-Smad1/5/8 was not present above Koller's sickle in embryos ablated with the D4MAb (O). Bar, 1,250 μm
in A; 9 μm in B–T.
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around Hensen's node, in the primitive streak (Figs. 4F and G) and at
the base of the streak. Following ablation of Myo/Nog cells in the
blastocyst, no G8+ cells were found in 12 stage 4 embryos (Figs. 4P–
T). Three out of four ablated embryos lacked staining for noggin
(Fig. 4P). The fourth embryo contained six Noggin+/G8− cells in the
anterior ectoderm. Follistatin, which was normally expressed in
Hensen's node, in a discrete arc of cells above the node (Figs. 4J and K)
and at the base of the streak, was not detected in two out of four
embryos (Fig. 4Q). Two other embryos contained only a few follistatin+
cells in the lateral epiblast. Staining for chordin inHensen's nodeand the
primitive streak was weaker in ablated than control embryos (Figs. 5I
and R). BMP4 was expressed in groups of cells in the lateral ectoderm
adjacent to the anterior portion of the primitive streak (Fig. 4M). An
additional cluster of BMP4+ cells was observed above the node in
ablated embryos (Fig. 4S). Whereas p-Smad1/5/8 was not detected in
the area surrounding Hensen's node (Fig. 4N) or primitive streak in
control embryos, ablated embryos contained strong p-Smad1/5/8
staining above the node (Fig. 4T) and along the margins of the streak.
These analyses demonstrate that although the majority of embryos do
form a primitive streak after ablating Myo/Nog cells in the blastocyst,
the morphology of the streak is abnormal and BMP signaling is
deregulated in the epiblast.
Ablation of Myo/Nog cells in the blastocyst disrupts morphogenesis
The effects of eliminating G8+ and D4+ cells in the blastocyst
on morphogenesis was determined by examining the structure of day
4–6 embryos. Ablation of D4+ epiblast cells resulted in a reduction in
the overall size of the embryo, but otherwise the embryos appeared to
have a normal morphology (n=5) (Fig. 5B). Other control embryos
treated with Hanks buffer or MAb or complement only (n=28) had
no visible morphological defects (Fig. 5A).Ablation of Myo/Nog cells in 28 stage X–XII embryos produced
defects of varying severity. Of the embryos treated with the G8 MAb
and complement, 33% formed cyst-like structures or masses of
morphologically unidentiﬁable, vascularized tissue (Fig. 5C). Five
embryos hadmissing or shortened trunks. All embryos that developed
a trunk exhibited ventral organ herniations, 11% had a twisted body
axis, 50% had limbs that projected dorsally or laterally instead of
ventrally (Figs. 5D–F), and two embryos were missing a head.
Malformations of the head, facial prominences and eyes were present
in 89% of ablated embryos. Examples of these defects were
anopthalmia, micropthalmia, cyclopia, facial clefting, absence of facial
structures (Figs. 5D–F) and an anterior proboscis. Externally visible
brain defects, including a lack of a forebrain vesicle, exencephaly
(Fig. 5D), open anterior neuropore and retroﬂexure of the forebrain
into hindbrain, were observed in 57% of the embryos. At the level of
the heart and above, the neural tube was open (Fig. 5I) and appeared
horizontal in some sections due to undulations along its length. Axial
defects improved below the heart. The neural tube was fused at the
level of the mesenephros (Fig. 5J). The dermomyotome/myotome,
sclerotome and notochord were present in ablated embryos (Figs. 5I
and J). In some sections, the shape of the dermomyotome/myotome
appeared distorted, a possible effect of undulations of the neural tube
Fig. 5J). Ninety three percent of stage X–XII ablated embryos exhibited
a more severe phenotype than embryos in which G8+ cells were
lysed at stage 2 (Gerhart et al., 2006).
Ablation of Myo/Nog cells affects skeletal myogenesis and neurogenesis
No G8+ cells were observed in sections through two 5-day
embryos following ablation of Myo/Nog cells in the blastocyst
(Fig. 6D). A third embryo contained three G8+ cells in one of the
left somites and in the notochord. Neither noggin nor follistatin was
found in sections from different levels of two embryos (Figs. 6D and
Fig. 4. Effects of Myo/Nog cell ablation on the expression of regulators of BMP signaling in gastrulating embryos. Untreated embryos (untx) and embryos incubatedwith complement
(cp) only or D4 and complement at stage X–XII displayed a normal primitive streak (ps) by stage 3–4 (A–C). G8 ablated embryos had primitive streaks of abnormal morphology and/
or positioning (D, E). Stage 3–4 embryos were double labeled with antibodies. The photographs of the embryos in A and D demonstrate the regions shown in the photomicrographs
of F–O and P–T, respectively. The colors of the ﬂuorescent tags are indicated in each panel. Overlap of red and green appears yellow in merged images. In untreated
embryos, G8+/noggin+(NogP) cells were present in the primitive streak (ps) (F) and Hensen's node (hn) (G). Chordin (Chor) was found in the primitive streak (H) and Hensen's
node (I). Staining for follistatin (Fol) was observed in the anterior primitive streak (J) and above Hensen's node (ahn) (K). BMP4 (L) and p-Smad1/5/8 (N) were absent in Hensen's
node but present in the lateral ectoderm (ec) (M and O). Staining for chordin, follistatin, BMP4 and p-Smad1/5/8 did not overlap with G8 (H–O). Neither G8, noggin nor follistatin
was detected in Hensen's node in embryos ablated with G8 and complement (P and Q). Staining for chordin was weaker in Hensen's node of G8 ablated embryos (R) compared to
untreated embryos (I). BMP4 (S) and p-Smad1/5/8 (T) were present above Hensen's node in G8 ablated embryos. Bar, 135 μm in A–E and 9 μm in F–T.
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tube. The somites lacked detectable levels of Pax3 andMyoD (Figs. 6H
and J). Small clusters of Pax3+/G8− cells were present outside of the
somites. BMP inhibitors and skeletal muscle markers were expressed
in the somites of control embryos treated with the D4 MAb and
complement (Figs. 6C, E, G, I and K). Sarcomeric myosin was abundant
in the myotome of D4 ablated embryos but was not detected in most
somite cells in ablated embryos (Fig. 6L). Staining for neuroﬁlament
associated antigen was weaker in the spinal cord and NOT1 was
reduced in the notochord of G8 ablated embryos (Figs. 6N and P)
compared to embryos ablated with the D4 MAb and complement
(Figs. 6M and O). Similar results were obtained when day 2–2.5
embryos were examined for the expression of markers of skeletal
myogenesis. At the level of the heart, somites from untreated embryos
(Figs. 7B–D), but not ablated embryos (Figs. 7H, I and L), contained
noggin, Pax3 and MyoD. A few sarcomeric myosin+ cells were
present in the somites of control and ablated embryos (Figs. 7D and I).
An inhibition of the emergence of Pax3+ skeletal muscle pro-
genitors in the somites of ablated embryos could result from a lack of
appropriate signals from axial structures. Stage 12–16 embryos were
analyzed for the expression of Sonic hedgehog (Shh), Wnt3a and
Wnt1, factors that promote the development of skeletal muscleprogenitor cells in the somites (Borycki et al., 1998; Christ and Huang,
2009; Fan et al., 1997; Munsterberg et al., 1995; Stern et al., 1995;
Tajbakhsh et al., 1998; Wagner et al., 2000). Shh was expressed in the
notochord and ﬂoor plate in both untreated and ablated embryos
(Figs. 7E and M). At the level of the heart, Wnt3a was localized to the
dorsal neural tube, dorsal ectoderm and a few cells in the somites of
untreated and two out of three ablated embryos (Figs. 7C and J).
Wnt3a was also found in the ventral neural tube and notochord of the
third ablated embryo (Fig. 7K). Wnt1 mRNA was observed in the
dorsal neural tube of control and ablated embryos (Figs. 7F and N).
Two ablated embryos also hadWnt1+ cells in the ventral neural tube
(Figs. 7N and O). The variations in staining indicate that ablation of
Myo/Nog cells affects the expression patterns of Wnts1 and 3a.
Subpopulations of somite cells from embryos lacking Myo/Nog cells
synthesize Pax3 in vitro and cardiac markers in vitro and in vivo
The potential of somite cells from ablated embryos to express
muscle genes was tested in vitro under conditions that were
optimized to promote skeletal myogenesis (George-Weinstein et al.,
1994). The majority of somite cells from untreated stage 12–13
embryos differentiated into skeletal muscle in culture; however, only
Fig. 5. Effects of Myo/Nog cell ablation on morphogenesis. Stage X–XII embryos were incubated with complement (cp) only or G8 or D4 MAb and complement, and grown to stage
25–26. Whole embryos and tissue sections stained with H&E were examined for malformations. Treatment with complement alone did not adversely affect morphogenesis (A and
G). Embryos treated with D4 and complement were smaller than control embryos (B and H). Ablation of G8+ cells produced cyst-like structures (C), herniated organs,
exenchephaly, anopthalmia, facial defects, abnormally projecting limbs (D), curvature of the body axis (E) and cyclopia (F). G8 ablated embryos also exhibited an open neural tube
(nt) and misshapen dermomyotome/myotome (dmm), sclerotome (sc) and notochord (nc) at the level of the heart (I). The neural tube was closed at the level of the mesonephros
(J). Bar, 2,500 μm in A–F; 135 μm in G, I, J; 41 μm in H.
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MyoD, sarcomeric myosin or the skeletal muscle speciﬁc 12101
antigen (Table 1). Approximately one third of the cells from ablated
embryos contained nuclear Pax3 staining. Cells expressing Pax3 were
adjacent to Wnt3a+ cells (Fig. 7P).
While some somite cells from ablated embryos synthesized
sarcomeric myosin in vitro and in vivo, the MF20 MAb used to
monitor terminal differentiation stains both skeletal and cardiac
muscle (Bader et al., 1982). The muscle lineages were further
distinguished by staining for GATA4 synthesized in cardiac progenitor
cells (Heikinheimo et al., 1994) and cardiac troponin I (CTpI)
speciﬁcally expressed in cardiomyocytes (Dhoot et al., 1978; Toyota
and Shimada, 1981). Only a few somite cells from normal embryos
were labeled with either antibody in vitro (Table 1). The percentages
of GATA4+ and CTpI+ cells were increased dramatically in cultures of
somite cells from ablated embryos (Table 1, Fig. 8B). In some cells,
CTpI appeared in a striated pattern along myoﬁbrils (Fig. 8B). Most
CTpI+ cells were broad, contained one or two nuclei and resembled
cardiomyocytes in cultures prepared from the heart, whereas the
skeletal myoﬁbers were long and thin, and some were multinucleated
(Figs. 8A–C). The expression of cardiac and skeletal muscle markers
was not signiﬁcantly affected by the addition of pieces of the neural
tube and notochord obtained from untreated embryos (Table 1).
Cardiac progenitors and cardiomyocytes were also present in the
somites of ablated, but not control embryos, in vivo (Figs. 8D, E, G andH).
GATA4+ and CTpI+ cells were found primarily in the myotome
(Figs. 8G and H). At the level of the heart, the myotomes of stage 12–13
ablated embryos contained 0–26GATA4+cells and 0–9 CTpI+ cells per
section. In 5–6 day embryos, sections contained 0–12GATA4+cells and
0–32 CTpI+ cells in the myotome. Cardiac progenitors and cardiomyo-
cytes were also found in the sclerotome (stages 12–13: 0–11 GATA4+
cells and 0–16 CTpI+ cells per section; days 5–6: 0–10 GATA4+ cells
and 0–5 CTp+ cells and 0–16 CTpI+ cells per section) (Fig. 8). Staining
for cardiac troponin Tdisplayed a similar pattern to that of CTpI (Figs. 8H
and I). These in vitro and in vivo experiments demonstrate thatcardiomyogenic cells are ectopically located in the somites following
ablation of Myo/Nog cells in the blastocyst.
Reintroduction of Myo/Nog cells into ablated embryos represses BMP
signaling in the epiblast and improves morphogenesis and differentiation
in older embryos
Stage X–XII embryos treated with the G8 MAb and complement
were implanted with G8+ cells isolated from the epiblasts of other
blastocysts to test whether they could rescue the Myo/Nog ablation
phenotype. Directly following magnetic cell sorting, 98%±4 (n=4),
91%±4 (n=4) and 58%±9 (n=7) of the cells in the G8+ population
were stained for MyoD and noggin mRNAs and noggin protein,
respectively. In the G8-negative (G8−) subpopulation, only 5%±5
(n=4), 1%±2 (n=4) and 0% (n=8) were positive for MyoD mRNA
and noggin mRNA and protein, respectively.
G8+ or G8− cells were microinjected into the posterior/medial
epiblast 45 min after ablatingMyo/Nog cells. By stage 2, 55±7 (n=3)
G8+ cells were positioned in the posterior/medial epiblast above
Koller's sickle and in the anterior portion of the developing streak of
ablated embryos (Figs. 9B, C and E). All G8+ cells expressed noggin
(Figs. 9B and C). Implantation of G8+ cells into ablated embryos
restored the normal pattern of follistatin expression (Fig. 9D) (n=3),
although the intensity of staining appeared weaker than that of
control embryos (Figs. 2H and I). Importantly, returning G8+ cells to
ablated embryos eliminated p-Smad1/5/8 staining within the epiblast
(Fig. 9E) but did not affect p-Smad1/5/8/staining below Koller's sickle
(Fig. 9F) (n=3), demonstrating that the implanted G8+ cells
repressed canonical BMP signaling in the epiblast.
Ablated embryos implanted with G8+ cells were grown for six
days and examined for malformations. Five out of nine of these
embryos had no externally visible defects (Fig. 10A). Three embryos
exhibited a partial correction of the defects in which an intact body
wall and normal limbs were accompanied by an open anterior
neuropore (Fig. 10B), missing eye or twisted body axis. Only one
Fig. 6. Effects of Myo/Nog cell ablation on the expression of markers for skeletal muscle, neurons and notochord cells. Stage X–XII embryos were treated with complement (cp) to
ablate G8+ or D4+ cells, grown to stage 25–26, sectioned and labeled with antibodies. The colors of the ﬂuorescent tags are indicated in each panel. The areas illustrated in the low
magniﬁcation images of H&E stained sections are shown in the ﬂuorescence micrographs. Overlap of red and green appears yellow in merged images. D4 ablated embryos contained
G8+/noggin+(Nog) cells (C) and cells with follistatin (Fol) (E), Pax3 (G), MyoD (I) and sarcomeric myosin (K) in the dermomyotome/myotome (dmm). Embryos ablated with the
G8MAb lacked G8 (D), noggin (D), follistatin (F), Pax3 (H), MyoD (J) and sarcomeric myosin (L) in the somites. Staining for neuroﬁlament associated antigen (nfa) in the neural tube
(N) and NOT1 in the notochord (P) were reduced in G8 ablated embryos compared to D4 ablated embryos (M and O). Bar, 27 μm in A; 56 μm in B; 9 μm in C–P.
19J. Gerhart et al. / Developmental Biology 359 (2011) 12–25embryo had the full spectrum of defects observed in ablated embryos.
Ablated embryos injected with G8− epiblast cells (n=8) continued
to exhibit head and body wall defects (Figs. 10C and D). Injection of
Hank's buffer diluted in the glycerol/fast green solution did not
produce visible malformations in four ablated embryos.
G8− cells that had been stained with Hoechst dye prior to
implantation were found in axial and paraxial structures; however,they did not restore the expression of BMP inhibitors or markers of
skeletal muscle, neurons and notochord cells, and GATA4 and CTpI
remained in the somites (Figs. 10F–M). Hoechst+/G8+ cells were
integrated into tissues where they are normally found in the embryo
(Gerhart et al., 2006), including the somites (Figs. 10Q and V).
Reintroduction of G8+ cells into ablated embryos promoted the
expression of noggin, follistatin, Pax3, MyoD and sarcomeric myosin
Fig. 7. Effects of Myo/Nog cell ablation on the expression of skeletal muscle markers, Shh and Wnts. Untreated (A–F) and G8 and complement treated (G–P) stage X–XII embryos
were incubated to stage 12–26. Sections at the level of the heart were labeled with antibodies and dendrimers. The colors of the ﬂuorescent tags are indicated in each panel. The areas
illustrated in A and G are shown in the ﬂuorescence photographs. Overlap of red and green appears yellow in merged images. Noggin, Pax3 (Pax), and MyoD were expressed in the
stage 12–17 dermomyotome/myotome (dmm) of the somites (s) of untreated (B–D) but not G8 ablated embryos (H, I, J, L). Sarcomeric myosin+ cells were present in the dmm of
control embryos (D) and in some (I), but not all sections (H, L) from ablated embryos. Untreated and ablated embryos contained Shh in the notochord (nc) and ﬂoor plate of the
neural tube (nt) (E, M) and Wnt3a in the nt and dmm (C, J, K). Wnt1 mRNA was localized to the dorsal nt of untreated embryos (F) and dorsal and ventral nt in ablated embryos
(N, O). Pax3+ cells were adjacent to Wnt3a+ cells in cultures of somite cells from stages 12 to 13, G8/complement treated embryos (P). Bar, 56 μm in A and G; 9 μm in B–F, H–P.
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antigen in the neural tube and NOT1 in the notochord, and eliminated
staining for GATA4 and CTpI in the somites (Figs. 10O–V). Theseexperiments illustrate that returning Myo/Nog cells to the epiblast
fully or partially rescues the phenotype of embryos ablated with the
G8 MAb and complement.
Table 1
Behavior of somite cells from embryos lacking Myo/Nog cells in vitro. Stage X–XII
embryos treated with the G8MAb and complement were grown for two days. Right and
left somites were removed from ablated (Abl) and untreated (Untx) embryos. Some
somite cells from ablated embryos were cultured with a piece of the neural tube (NT)
and notochord (NC) dissected from untreated embryos. Cells were stained with
antibodies to G8, muscle proteins and noggin on the ﬁfth day in culture. A minimum of
400 cells were scored per culture. Values are the mean±standard deviation of the
percent of the total number of cells that were stained with antibody. The number of
cultures scored is indicated in parentheses. With the exception of Wnt3a, statistically
signiﬁcant differences were found between untreated and ablated cultures with or
without the neural tube and notochord (MyoD, myosin, 12101, GATA4 and CTpI:
pb0.0001; Pax3, G8, and noggin: p≤0.07, 0.02, 0.01, respectively).
Untx Abl Abl+NT/NC
Pax3 22±10 (12) 37±17 (8) 39±21 (5)
MyoD 22±12 (14) 2±4 (13) 6±5 (5)
Myosin 65±15 (13) 18±17 (13) 4±8 (5)
12101 42±18 (11) 1±2 (9) 4±6 (5)
G8 55±17 (4) 2±3 (4) 0.2±0.1 (5)
Wnt3a 22±21 (12) 31±17 (8) 19±3 (5)
Noggin 31±24 (5) 0.5±0.4 (4) 0.4±0.6 (4)
GATA4 1±1 (14) 50±17 (16) 50±10 (4)
CTpI 0.3±0.4 (14) 18±11 (15) 13±7 (4)
Fig. 8. Expression of cardiac markers in somite cells from embryos lacking Myo/Nog cells. So
13 embryos. Somite cells from untreated embryos formed sarcomeric myosin+, elongated
troponin I+(CTpI) cells (B). Some cardiomyocytes contained striations (arrows in B). CTpI+
In vivo, the somites of G8 ablated (G, H) but not untreated (D, E) stage 12–16 (D, G) and s
T (CTpT) was expressed in stage 25–26 ablated (I) but not untreated embryos (F). Bar, 9 μm
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Our quest for elucidating the molecular and cellular events
involved in the development of the skeletal muscle lineage led to
the discovery of Myo/Nog cells, a unique population that plays a
critical role in regulating cell behavior in a variety of tissues (Gerhart
et al., 2004b, 2006, 2009). While Myo/Nog cells are capable of forming
skeletal myoﬁbers when cultured under permissive conditions
(Gerhart et al., 2004b; Strony et al., 2005), in vivo, they release
noggin to regulate the differentiation of skeletal muscle progenitor
cells in the somites and eye morphogenesis (Gerhart et al., 2006,
2009). In this study we revealed that MyoDmRNA+/G8+ cells are an
indispensible source of noggin in the epiblast itself and their
elimination in the blastocyst has profound consequences on embry-
onic development.
Ablation of Myo/Nog cells in the blastocyst disrupts the develop-
ment of axial and paraxial structures. Although these effects can be
explained by aberrant BMP signaling during gastrulation and
neurulation, comparisons of embryos in which Myo/Nog cells were
ablated in stage 1 versus stage 2 embryos illustrate a more
complicated scenario for the roles of these cells during earlymite cultures were prepared from untreated and G8 and complement treated stage 12–
skeletal myotubes (A). Cultures from ablated embryos contained GATA4+ and cardiac
cells in somite cultures resembled cultured cardiomyocytes from the stage 12 heart (C).
tage 25–26 embryos (E and H) contained GATA4+ and CTpI+ cells. Cardiac troponin
.
Fig. 9. Effects of reintroducing Myo/Nog cells into ablated embryos on regulators of BMP signaling in the stage 2 epiblast. G8+ cells isolated from stage X–XII embryos were injected
into the epiblast after the indigenous population of G8+ cells was ablated with complement. Embryos were grown to stage 2 and double labeled with antibodies. The photograph of
the stage 2 embryo (A) illustrates the regions shown in the ﬂuorescence micrographs. The colors of the ﬂuorescent tags are indicated in each panel. Overlap of red and green appears
yellow in merged images. Implanted G8+ cells synthesized noggin in the posterior/medial epiblast (pme) (B) and in the anterior portion of the developing primitive streak (as) (C),
restored expression of follistatin in the posterior/lateral epiblast (ple) (D) and inhibited p-Smad1/5/8 accumulation in the epiblast in the pme (E). P-Smad1/5/8 was present below
Koller's sickle (bks) (F). Bar, 900 μm in A; 9 μm in B–F.
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in the blastocyst are more severe than when they are targeted six
hours later during early stages of primitive streak formation (Gerhart
et al., 2006, 2009). The probable cause of the more severe phenotype
with earlier ablation is the expansion of BMP signaling that occurs
prior to the initiation of gastrulation. Deregulation of BMP signaling in
the blastula and gastrula is likely to affect other signaling pathways
and contribute to abnormal morphogenesis and altered differentia-
tion during neurogenesis and somitogenesis.
The ﬁrst structural sign of disrupted development is a dysmorphic
or absent primitive streak. These effects of ablating Myo/Nog cells in
the early embryo are consistent with the results of Streit et al. (1998)
who demonstrated that misexpression of BMP4 inhibits primitive
streak formation. It is not clear whether Myo/Nog cells actively or
passively accumulate in the developing and elongating streak.
However, their capacity to migrate in response to apoptosis within
the epiblast raises the possibility that Myo/Nog cells play a role in the
convergence and extension movements along the midline of the
embryo apart from their production of noggin.
In many respects, embryos lacking Myo/Nog cells resemble noggin
null mouse embryos that exhibit neural tube defects, enlargement of
the notochord and decreased skeletal muscle in the somites
(Anderson et al., 2002; Bachiller et al., 2000; Brunet et al., 1998;
Choi et al., 2007; McMahon et al., 1998; Que et al., 2006; Stottmann et
al., 2006;Weaver et al., 2003). One difference between these embryos
is that follistatin is present in the somites of noggin null embryos
(McMahon et al., 1998) but not in chick embryos lacking Myo/Nog
cells. Chordin and other BMP inhibitors may compensate for the lack
of noggin more effectively in the mouse than the chick embryo to
restrain BMP signaling and promote follistatin expression. Variation in
chordin expression in chick embryos lacking Myo/Nog cells may be
responsible for the range in severity of the Myo/Nog ablation
phenotype that resembles either the double noggin/chordin knockout
mouse with defects in forebrain, eye and facial development
(Anderson et al., 2002; Bachiller et al., 2000) or the triple noggin/
chordin/follistatin knockdown in Xenopus embryos that lack neural
and dorsal mesoderm tissue (Khokha et al., 2005).
Another difference between embryos lacking Myo/Nog cells and
noggin null embryos is that Pax3+ skeletal muscle progenitor cells
are present in the murine somites. Both ablated chick and noggin−/−
embryos express Shh and Wnt1 in the notochord and neural tube
(present study andMcMahon et al., 1998). Culturing somite cells from
chick embryos lacking Myo/Nog cells revealed the potential of asubpopulation to express Pax3. Since the Pax3+ cells were adjacent to
those synthesizing Wnt3a in vitro, it is possible that in vivo, the
amount or distribution of Wnts within the paraxial mesoderm was
inadequate to support the speciﬁcation of somite cells to the skeletal
muscle lineage.
Altered interactions with axial structures do not appear to be the
only cause of disrupted skeletal myogenesis in chick embryos lacking
Myo/Nog cells. Subpopulations of somite cells in these embryos
express the cardiac markers GATA4 and cardiac troponins I and T. The
presence of cardiac progenitors and cardiomyocytes in the somites of
ablated embryos can be interpreted to mean that the default pathway
of paraxial mesoderm cells in the absence of sufﬁcient inducers of the
skeletal muscle lineage and unabated BMP signaling is cardiomyo-
genesis. Alternatively, not all somite cells in ablated embryos may be
competent to respond to inducers of skeletal myogenesis because
they are stably speciﬁed to the cardiac lineage. We favor the latter
hypothesis for the following reasons. Our cell culture conditions
clearly favor skeletal myogenesis, and yet a signiﬁcant number of
somite cells from ablated embryos express GATA4 and differentiate
into cardiomyocytes. Culturing somite cells from ablated embryos
with a neural tube and notochord from a normal embryo does not
reduce the percentage of cardiac cells. Furthermore, Myo/Nog cell
ablation results in an expansion of the domain of BMP signaling
during primitive streak formation and the initiation of gastrulation
when BMPs are involved in regulating early stages of cardiomyogen-
esis (van Wijk et al., 2007). Finally, when stage 2 epiblast cells are
cultured in the absence of Myo/Nog cells, they differentiate into
cardiac instead of skeletal muscle (Gerhart et al., 2004b). Analyses of
the effects of Myo/Nog cell ablation on the expression of cardiac
markers in the early embryo and the development of the heart are
expected to reveal a critical role for Myo/Nog cells in regulating the
size of the pool of cardiac progenitor cells.
The functions of Myo/Nog cells continue to expand as we examine
their behaviors in different tissues as development progresses.
Regardless of their location in the embryo, these cells display the
signature of their phenotype, i.e., the expression of MyoD mRNA, the
G8 antigen and noggin (Gerhart et al., 2006, 2007, 2009). Their
stability as a noggin delivery system in the epiblast, muscle and non-
muscle tissues indicates that Myo/Nog cells represent a unique
population whose function is to modulate the activities of BMPs from
the blastocyst stage through the period of organogenesis. Additional
behaviors of these cells were revealed in their response to apoptosis in
the epiblast (present study) and wounding of the lens epithelium
Fig. 10. Effects of reintroducing Myo/Nog cells into ablated embryos on morphogenesis and expression of BMP inhibitors and cell type speciﬁc markers in 5-day embryos. G8+ and
G8− cells isolated from stage X–XII embryos were injected into the epiblast after the indigenous population of G8+ cells was ablated with complement. Embryos were grown to
stages 24–26, analyzed for gross abnormalities, sectioned and labeled with antibodies. Implantation of G8+ cells (A and B), but not G8− cells (C and D), completely or partially
restored morphogenesis. The embryo in B exhibited an open anterior neuropore (arrow). Structures identiﬁed in the H&E stained sections of ablated embryos implanted with G8+
(E) or G8− cells (N) are shown in the merged images of DIC and ﬂuorescence. Implantation of G8+ cells (F–M) but not G8− cells (O–V) restored expression of noggin (Nog),
follistatin (Fol), Pax3, MyoD and sarcomeric myosin in the dermomyotome/myotome (dmm), increased expression of neuroﬁlament associated antigen (nfa) in the neural tube (nt)
and NOT1 in the notochord (nc), and eliminated GATA4 and cardiac troponin I (CtpI) in the somites. Hoechst stained, injected G8+ cells are visible in the somite (arrows in H and V).
Bar, 2500 μm in A–D; 135 μm in E, N; 9 μm in F–M, O–V.
23J. Gerhart et al. / Developmental Biology 359 (2011) 12–25(Walker et al., 2010). Given the importance of regulating BMP
signaling and maintaining tissue integrity, it is not surprising that
Myo/Nog cells emerge and function prior to the onset of gastrulation.
Myo/Nog cells may be vulnerable to teratogens or mutations in genes
coding for mediators of signaling pathways that affect their viability,
migration, function and/or proliferation. In this regard, it is possible
that Myo/Nog cell dysfunction underlies the cause of some birth
defects of unknown etiology.
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